MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
MYLAN PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL in Canada?
Yes. MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL 200MG 300MG has an active shortage reported to Health Canada (last updated May 21, 2025).
Why is MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02443902
Strength
200MG 300MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Disruption of the manufacture of the drug.
Disruption of the manufacture of the drug.
Delay in shipping of the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243